Lineage Cell Therapeutics Inc (LCTX) Insider Trading
In the last 90 days, 6 Lineage Cell Therapeutics Inc (LCTX) insiders reported 6 open-market purchases totaling $2,395,298 and no sales. The most recent open-market purchase was reported on Nov 17, 2026. Source: SEC Form 4 filings.
SEC-reported filing activity is provided for research purposes and is not investment advice.
- 90-day C-suite buyers
- 1
- 90-day purchase value
- $2,395,298
- Corporate buyers
- 6
- Latest transaction
- Nov 17, 2026
Executive filings
Open-market transaction history
Purchase and sale summaries are ordered by the latest reported transaction date.
Common questions
LCTX insider trading FAQ
- Are LCTX insiders buying or selling?
- Over the last 90 days, LCTX insiders were net buyers, reporting $2,395,298 of open-market purchases and $0.00 of sales.
- When was the last LCTX insider purchase?
- The most recent open-market purchase of Lineage Cell Therapeutics Inc stock by an insider was reported on Nov 17, 2026, one of 6 purchases in the last 90 days.
- Where does LCTX insider trading data come from?
- Watch Insiders reads the SEC Form 4 filings that Lineage Cell Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.
Related tickers with recent insider filings
- UTHR insider tradingUnited Therapeutics Corp73 filings
- TWST insider tradingTwist Bioscience Corp31 filings
- NTRA insider tradingNatera Inc28 filings
- ARTV insider tradingArtiva Biotherapeutics Inc20 filings
- RVMD insider tradingRevolution Medicines Inc20 filings
- TEM insider tradingTempus AI Inc20 filings
- CSTL insider tradingCastle Biosciences Inc19 filings
- PACS insider tradingPACS Group Inc.19 filings
